2010
DOI: 10.1208/s12249-010-9404-1
|View full text |Cite
|
Sign up to set email alerts
|

Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir

Abstract: Ritonavir is an antiretroviral drug characterized by low solubility and high permeability which corresponds to BCS class II drug. The purpose of the study was to develop solid dispersion by different methods and investigate them for in vitro and in vivo performance for enhancing dissolution and bioavailability, respectively. Since the drug possesses food-related absorption, the effect of biorelevant media (FaSSIF and FeSSIF state) on dissolution behavior was also studied. The solid dispersion was prepared usin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
104
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 186 publications
(114 citation statements)
references
References 15 publications
2
104
0
Order By: Relevance
“…In the spectra of the SRSD shown in Fig. 2e, the spectra of the SRSD and the PM were quite superimposable, except the absorption band of OH for CA and Cur which was shifted toward the lower frequency of 3,403 cm −1 , indicating the formation of an intermolecular hydrogen bond which would result in the increased solubility/dissolution of drug (22). However, no additional peak was observed depicting the absence of any chemical interaction between the drug and the carrier.…”
Section: Ftir Spectroscopymentioning
confidence: 95%
“…In the spectra of the SRSD shown in Fig. 2e, the spectra of the SRSD and the PM were quite superimposable, except the absorption band of OH for CA and Cur which was shifted toward the lower frequency of 3,403 cm −1 , indicating the formation of an intermolecular hydrogen bond which would result in the increased solubility/dissolution of drug (22). However, no additional peak was observed depicting the absence of any chemical interaction between the drug and the carrier.…”
Section: Ftir Spectroscopymentioning
confidence: 95%
“…2b) ), F6 displaying the lowest value (1.12 J g −1 ), and F7 showing a complete absence of the drug peak. It was speculated that the decrease in intensity of the SMX peak is attributed to the dissolving of SMX within the melted menthol during DSC measurements and as a result, distinct endothermic peaks corresponding to the melting of menthol was observed (25)(26)(27). In addition, the results may indicate that the degree of crystallinity was substantially reduced and the SMX was present in an amorphous form within the solid dispersion, thus accounting for the reduced intensity and shifting peaks (25,26).…”
Section: Thermal Analysis Of the Smx-loaded Solid Dispersionsmentioning
confidence: 99%
“…Various strategies have been used to overcome the problems associated with oral absorption and bioavailability issues of poorly soluble drugs, such as particle size reduction (Aungst, 1993), complexation with cyclodextrins (Miyake et al, 2000), salt formation, solid dispersions (Sinha et al, 2010), use of surfactant, nanoparticles, nanocarriers (Bali et al, 2011), Nanoemulsions , self-emulsifying drug delivery system , prodrug formation, etc. Approaches used in past to improve the dissolution and bioavailability of NRG include complexation with b-cyclodextrin (Tommasini et al, 2004), phospholipid complexes (Semalty et al, 2010), solid dispersion with PVP (Kanaze et al, 2006), etc.…”
Section: Introductionmentioning
confidence: 99%